797 reports of this reaction
2.2% of all VALGANCICLOVIR HYDROCHLORIDE reports
#8 most reported adverse reaction
ACUTE KIDNEY INJURY is the #8 most commonly reported adverse reaction for VALGANCICLOVIR HYDROCHLORIDE, manufactured by H2-Pharma, LLC. There are 797 FDA adverse event reports linking VALGANCICLOVIR HYDROCHLORIDE to ACUTE KIDNEY INJURY. This represents approximately 2.2% of all 36,658 adverse event reports for this drug.
Patients taking VALGANCICLOVIR HYDROCHLORIDE who experience acute kidney injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACUTE KIDNEY INJURY is a less commonly reported adverse event for VALGANCICLOVIR HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to acute kidney injury, the following adverse reactions have been reported for VALGANCICLOVIR HYDROCHLORIDE:
The following drugs have also been linked to acute kidney injury in FDA adverse event reports:
ACUTE KIDNEY INJURY has been reported as an adverse event in 797 FDA reports for VALGANCICLOVIR HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACUTE KIDNEY INJURY accounts for approximately 2.2% of all adverse event reports for VALGANCICLOVIR HYDROCHLORIDE, making it a notable side effect.
If you experience acute kidney injury while taking VALGANCICLOVIR HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.